Genmab — August 2018
-
@mollegade Søren Løntoft fra Sydbank har på det seneste haft en Begivenhedskalender med i sine analyser på GEN. Du kan finde en sådan analyse (20.06.2018, "Genmab: Darzalex fortsætte fremmarchen i USA", side 2) på den frie Sydbank Investor+ hjemmeside: https://www.sydbank.dk/investorplus/login/analyser
-
Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. https://www.ncbi.nlm.nih.gov/pubmed/30080247
-
Hej Raffles og Stroka, Tak for skarpe spørgsmål til Q&A. Alle andre må også meget gerne fyre løs.

-
-
-
-
Ha ha

-
Tre sjæle - en tanke.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind